Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Bucci
Frank A
FA
Waterbury
L David
LD
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics* / Q000494:pharmacology*; D001082:Aqueous Humor / Q000378:metabolism*; D019540:Area Under Curve; D044482:Benzeneacetamides / Q000493:pharmacokinetics / Q000494:pharmacology; D001577:Benzophenones / Q000493:pharmacokinetics / Q000494:pharmacology; D001682:Biological Availability; D001969:Bromobenzenes / Q000493:pharmacokinetics / Q000494:pharmacology; D002387:Cataract Extraction; D002851:Chromatography, High Pressure Liquid; D051545:Cyclooxygenase 1 / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism; D006801:Humans; D020910:Ketorolac / Q000493:pharmacokinetics / Q000494:pharmacology; D010648:Phenylacetates / Q000493:pharmacokinetics / Q000494:pharmacology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044482:Benzeneacetamides; D001577:Benzophenones; D001969:Bromobenzenes; D016861:Cyclooxygenase Inhibitors; D010648:Phenylacetates; C414203:nepafenac; C014285:amfenac; C053083:bromfenac; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D015232:Dinoprostone; D020910:Ketorolac